These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Practical considerations for carbamazepine use in bipolar disorder. Fuller MA; Dostrow V; Gupta S; Gazda TD Expert Opin Drug Saf; 2006 Jul; 5(4):501-9. PubMed ID: 16774489 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder. Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118 [TBL] [Abstract][Full Text] [Related]
17. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial. Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797 [TBL] [Abstract][Full Text] [Related]
18. Historical review of carbamazepine for the treatment of bipolar disorder. Stoner SC; Nelson LA; Lea JW; Marken PA; Sommi RW; Dahmen MM Pharmacotherapy; 2007 Jan; 27(1):68-88. PubMed ID: 17192163 [TBL] [Abstract][Full Text] [Related]
19. Switching from other agents to extended-release carbamazepine in acute mania. El-Mallakh RS; Ketter TA; Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Keck P; Swann AC; Kalali AH Psychopharmacol Bull; 2008; 41(1):52-8. PubMed ID: 18362871 [TBL] [Abstract][Full Text] [Related]
20. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. Joshi G; Wozniak J; Mick E; Doyle R; Hammerness P; Georgiopoulos A; Kotarski M; Aleardi M; Williams C; Walls S; Biederman J J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):7-14. PubMed ID: 20166791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]